Sign in

NCT07023536Recruiting

Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure

Evaluation of the Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure

Source: ClinicalTrials.gov · Last updated 11 Mar 2026

Brief summary (registry, in English)

The goal of this observational study is to evaluate whether a home-based cardiac tele-rehabilitation program can improve functional capacity in adults (18 years and older) with chronic heart failure. The main questions it aims to answer are: Does tele-rehabilitation improve peak oxygen uptake (VO₂ max) compared to standard in-hospital rehabilitation? Does it improve cardiac function, exercise tolerance, biochemical markers, and quality of life? Are functional gains maintained at 24 weeks? Researchers will compare patients who opt for tele-rehabilitation using wearable devices and a remote monitoring platform with those undergoing standard in-person rehabilitation. Participants will follow an 8-week individualized training program and undergo assessments at baseline, 4, 8, 16, and 24 weeks.

Status (registry)
Recruiting
Study type
Observational
Enrollment
205 (estimated)
First submitted
8 Jun 2025
Start date
10 Jun 2025
Primary completion date
1 Jul 2026
Lead sponsor
University of Salerno
NCT number
NCT07023536

What you commit to

  • Study type: Observational
  • Planned participants: 205
  • From 10 Jun 2025 to the primary completion date, 1 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • NYHA class IV heart failure
  • Other serious illnesses significantly limiting life expectancy (e.g., end-stage cancer, advanced pulmonary disease)

Lab values

  • Severe renal insufficiency (eGFR \<30 ml/min/1.73 m²) or on dialysis

Age

  • Age \< 18 years

Other

  • Pregnancy

Who the study is looking for

  • Age ≥ 18 years
  • Diagnosis of chronic heart failure for at least 6 months, with stable optimal medical therapy for at least 1 month
  • New York Heart Association (NYHA) functional class I, II, or III
  • Hospitalization or outpatient visit requiring intravenous therapy (diuretics, vasodilators, or inotropes) within the past 12 months
  • Ability to provide informed consent or presence of a legal representative
  • Digital literacy of the patient and/or caregiver

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital University San Giovanni di Dio e Ruggi d'Aragona
Coordinator of this site? Confirm its status
SalernoItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.